Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 25:S0015-0282(17)31748-X.
doi: 10.1016/j.fertnstert.2017.08.026. Online ahead of print.

Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women

Aimee Seungdamrong  1 , Anne Z Steiner  2 , Clarisa R Gracia  3 , Richard S Legro  4 , Michael P Diamond  5 , Christos Coutifaris  6 , William D Schlaff  7 , Peter Casson  8 , Gregory M Christman  9 , Randal D Robinson  10 , Hao Huang  11 , Ruben Alvero  7 , Karl R Hansen  12 , Susan Jin  11 , Esther Eisenberg  13 , Heping Zhang  11 , Nanette Santoro  7 ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Reproductive Medicine Network
Affiliations

Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women

Aimee Seungdamrong et al. Fertil Steril. .

Abstract

Objective: To study whether preconceptual thyroid-stimulating hormone (TSH) and antithyroid peroxidase (TPO) antibodies are associated with poor reproductive outcomes in infertile women.

Design: Secondary analysis of data from two multicenter, randomized, controlled trials conducted by the Reproductive Medicine Network of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Multivariable logistic regression analyses were performed to assess the association between preconceptual TSH levels and anti-TPO antibodies.

Setting: Not applicable.

Patient(s): Serum samples from 1,468 infertile women were utilized.

Intervention(s): None.

Main outcome measure(s): Cumulative conception, clinical pregnancy, miscarriage, and live birth rates were calculated.

Result(s): Conception, clinical pregnancy, miscarriage, and live birth rates did not differ between patients with TSH ≥2.5 mIU/L vs. TSH < 2.5 mIU/L. Women with anti-TPO antibodies had similar conception rates (33.3% vs. 36.3%) but higher miscarriage rates (43.9% vs. 25.3%) and lower live birth rates (17.1% vs. 25.4%) than those without anti-TPO antibodies. Adjusted, multivariable logistic regression models confirmed elevated odds of miscarriage (odds ratio 2.17, 95% confidence interval 1.12-4.22) and lower odds of live birth (oddr ratio 0.58, 95% confidence interval 0.35-0.96) in patients with anti-TPO antibodies.

Conclusion(s): In infertile women, preconceptional TSH ≥2.5 mIU/L is not associated with adverse reproductive outcomes; however, anti-TPO antibodies are associated with increased risk of miscarriage and decreased probability of live birth.

Clinical trial registration number: PPCOS II NCT00719186; AMIGOS NCT01044862.

Keywords: Antibodies; autoimmunity; infertility; pregnancy; spontaneous abortion; thyroid.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Adjusted odds ratios for pregnancy outcomes by TSH levels and anti-TPO antibodies. First trimester pregnancy loss refers to the pregnancy losses prior to 13 weeks gestation.
See this image and copyright information in PMC

References

    1. van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2011;17(5):605–619. - PubMed
    1. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543–2565. - PubMed
    1. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab. 2010;95(9):E44–48. - PubMed
    1. Colicchia M, Campagnolo L, Baldini E, Ulisse S, Valensise H, Moretti C. Molecular basis of thyrotropin and thyroid hormone action during implantation and early development. Hum Reprod Update. 2014;20(6):884–904. - PubMed
    1. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499. - PubMed

Associated data